Janpix Inc.
Industry
- Biotechnology
- Pharmaceuticals
See more in Biomedtracker
Latest on Janpix Inc.
In Vivo
• By William Masters
Founded by UK life sciences venture capital firm Medicxi, Centessa Pharmaceuticals is headed up by industry heavyweights. Saurabh Saha, who was formerly Bristol Myers Squibb Company ’s head of R&D
Scrip
• By William Masters
Centessa Pharmaceuticals has launched with a first-of-its-kind model involving the merger of ten biotechs and $250m in series A backing. The new company was created through the merger of ten private
Scrip
• By Mandy Jackson
Venture capital fundraising by biopharmaceutical companies in 2020 totaled $19.5bn during the first three quarters of 2020, which beats the full year 2019 total of $17.4bn and is on track to surpass t